600566 濟川藥業
按盤價 
29.740 +0.020 (+0.067%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 13.879 | 22.869 | 21.226 | 20.369 | 18.420 |
| 總資產報酬率 ROA (%) | 10.485 | 17.043 | 16.013 | 15.182 | 13.318 |
| 投入資產回報率 ROIC (%) | 12.357 | 20.822 | 19.532 | 18.433 | 16.493 | 邊際利潤分析 |
| 銷售毛利率 (%) | 79.258 | 81.522 | 82.911 | 83.270 | 81.667 |
| 營業利潤率 (%) | 36.513 | 33.747 | 26.939 | 25.330 | 23.828 |
| 息稅前利潤/營業總收入 (%) | 34.936 | 31.484 | 26.924 | 24.395 | 23.284 |
| 淨利潤/營業總收入 (%) | 32.856 | 29.282 | 24.140 | 22.505 | 20.717 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 86.195 | 95.177 | 94.725 | 90.637 | 97.034 |
| 價值變動淨收益/利潤總額(%) | 5.247 | 2.922 | 2.348 | 8.282 | 1.504 |
| 營業外收支淨額/利潤總額(%) | 5.097 | 1.181 | 3.366 | 0.903 | 0.980 | 償債能力分析 |
| 流動比率 (X) | 3.724 | 3.100 | 3.261 | 2.900 | 3.343 |
| 速動比率 (X) | 3.551 | 2.993 | 3.147 | 2.766 | 3.201 |
| 資產負債率 (%) | 22.348 | 26.317 | 24.222 | 24.730 | 26.176 |
| 帶息債務/全部投入資本 (%) | 9.827 | 9.595 | 4.995 | 7.595 | 7.288 |
| 股東權益/帶息債務 (%) | 904.531 | 929.452 | 1,868.877 | 1,190.599 | 1,242.862 |
| 股東權益/負債合計 (%) | 346.868 | 279.579 | 312.426 | 303.897 | 282.026 |
| 利息保障倍數 (X) | -9.874 | -11.805 | -28.242 | -20.923 | -29.858 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 106.873 | 103.627 | 98.903 | 95.507 | 110.495 |
| 存貨周轉天數 (天) | 129.356 | 88.946 | 89.808 | 92.218 | 98.245 |
| 備註： | 即時報價更新時間為 19/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
